ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 358 filers reported holding ENCOMPASS HEALTH CORP in Q3 2019. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $8,099,434 | -2.4% | 94,410 | -6.1% | 0.07% | +4.8% |
| Q1 2024 | $8,302,593 | +17.9% | 100,540 | -4.7% | 0.06% | +18.9% |
| Q4 2023 | $7,041,629 | -0.7% | 105,540 | 0.0% | 0.05% | -5.4% |
| Q3 2023 | $7,088,066 | -14.7% | 105,540 | -14.0% | 0.06% | -8.2% |
| Q2 2023 | $8,310,725 | +23.5% | 122,740 | -3.1% | 0.06% | +15.1% |
| Q1 2023 | $6,730,508 | -11.2% | 126,680 | 0.0% | 0.05% | -10.2% |
| Q4 2022 | $7,576,731 | +25.9% | 126,680 | -4.8% | 0.06% | +13.5% |
| Q3 2022 | $6,016,000 | -19.3% | 133,000 | 0.0% | 0.05% | -16.1% |
| Q2 2022 | $7,455,000 | -17.1% | 133,000 | +5.2% | 0.06% | -7.5% |
| Q1 2022 | $8,994,000 | +38.9% | 126,480 | +27.4% | 0.07% | +45.7% |
| Q4 2021 | $6,477,000 | -4.3% | 99,250 | +10.1% | 0.05% | -14.8% |
| Q3 2021 | $6,766,000 | +38.6% | 90,160 | +44.1% | 0.05% | +45.9% |
| Q2 2021 | $4,882,000 | +3.6% | 62,560 | +8.7% | 0.04% | -2.6% |
| Q1 2021 | $4,713,000 | +39.1% | 57,540 | +40.4% | 0.04% | +35.7% |
| Q4 2020 | $3,389,000 | +42.8% | 40,980 | +12.2% | 0.03% | +33.3% |
| Q3 2020 | $2,374,000 | +41.6% | 36,530 | +34.9% | 0.02% | +31.2% |
| Q2 2020 | $1,677,000 | +15.3% | 27,080 | +19.2% | 0.02% | 0.0% |
| Q1 2020 | $1,454,000 | -17.2% | 22,710 | -10.3% | 0.02% | -5.9% |
| Q4 2019 | $1,755,000 | +12.2% | 25,330 | +2.5% | 0.02% | 0.0% |
| Q3 2019 | $1,564,000 | +12.6% | 24,720 | +12.8% | 0.02% | +6.2% |
| Q2 2019 | $1,389,000 | +17.0% | 21,920 | +7.9% | 0.02% | +14.3% |
| Q1 2019 | $1,187,000 | +12.3% | 20,320 | +18.6% | 0.01% | -6.7% |
| Q4 2018 | $1,057,000 | -7.9% | 17,130 | +16.3% | 0.02% | +7.1% |
| Q3 2018 | $1,148,000 | +5.9% | 14,730 | -8.0% | 0.01% | -6.7% |
| Q2 2018 | $1,084,000 | +18.5% | 16,010 | 0.0% | 0.02% | +25.0% |
| Q1 2018 | $915,000 | +21.0% | 16,010 | +4.6% | 0.01% | +20.0% |
| Q4 2017 | $756,000 | – | 15,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DARUMA CAPITAL MANAGEMENT LLC | 587,603 | $45,804,000 | 4.32% |
| Kalos Management, Inc. | 77,043 | $6,000,000 | 3.22% |
| MARIETTA INVESTMENT PARTNERS LLC | 101,122 | $7,882,000 | 2.34% |
| Copeland Capital Management, LLC | 471,462 | $36,750,000 | 2.22% |
| REINHART PARTNERS, LLC. | 278,916 | $21,742,000 | 1.97% |
| Rock Springs Capital Management LP | 676,500 | $52,733,000 | 1.91% |
| Wolf Group Capital Advisors | 35,599 | $2,775,000 | 1.81% |
| GARRISON BRADFORD & ASSOCIATES INC | 27,608 | $2,152,000 | 1.73% |
| BROADVIEW ADVISORS LLC | 123,907 | $9,659,000 | 1.65% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 70,000 | $5,457,000 | 1.64% |